Rapid Novor
Rapid Novor is a biotech company. It has raised $5.0M across 1 round, most recently a $5.0M Series A in August 2020.
Antibody Characterization & Discovery CRO
- Website
- rapidnovor.com
- Total Funding
- $5.0M
- Last Round
- $5.0M Series AAug 2020
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 1 funding round and 1 investor for this company. The full record is or through the API.
About
Rapid Novor offers antibody protein characterization and discovery services, powered by mass spectrometry: de novo sequencing, HDX, SPR, more
Summary
It has raised $5.0M in total across 1 round, most recently a $5.0M Series A round in Aug 2020. Investors include Cowin Ventures.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Aug 2020
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/rapid-novor"><img src="https://indexed.vc/api/badge/company/rapid-novor" alt="Rapid Novor on Indexed.vc" width="260" height="76" /></a>